Form 4 Tracker
Neil Kumar

Director; Director, Chief Executive Officer · 15 filings · Latest: Sep 17, 2026

BridgeBio Oncology Therapeutics, Inc.
BridgeBio Pharma, Inc.
Maze Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BBIO
NEIL KUMAR—Feb 19, 2026
Proposed Sale
$73.9328,053$2.1M—
BBIO
Neil KumarDirector, Chief Executive OfficerFeb 16, 2026
Option Exercise
—64,698—293,474
BBIO
Neil KumarDirector, Chief Executive OfficerFeb 11, 2026
Sale
$71.7840,000$2.9M4,478,447
BBIO
Neil KumarDirector, Chief Executive OfficerFeb 10, 2026
Sale
$71.9440,000$2.9M4,498,447
BBIO
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018—Jan 8, 2026
Proposed Sale
$74.27120,000$8.9M—
BBIO
KUMAR HALDEA FAMILY IRREVOCABLE TRUST—Jan 8, 2026
Proposed Sale
$74.27100,000$7.4M—
BBIO
NEIL KUMAR—Dec 15, 2025
Proposed Sale
$75.1530,011$2.3M—
BBIO
NEIL KUMAR—Nov 20, 2025
Proposed Sale
$65.5426,156$1.7M—
BBIO
KUMAR HALDEA FAMILY IRREVOCABLE TRUST—Oct 8, 2025
Proposed Sale
$54.22120,000$6.5M—
BBIO
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018—Oct 8, 2025
Proposed Sale
$54.22120,000$6.5M—
BBIO
NEIL KUMAR—Aug 20, 2025
Proposed Sale
$48.9126,156$1.3M—
BBIO
KUMAR HALDEA REVOCABLETRUST U/A DTD 12/19/2018—Jul 1, 2025
Proposed Sale
$43.18120,000$5.2M—
BBIO
KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019—Jul 1, 2025
Proposed Sale
$43.18120,000$5.2M—
BBIO
NEIL KUMAR—May 19, 2025
Proposed Sale
$33.8426,156$885.1K—
BBIO
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018—Feb 25, 2025
Proposed Sale
$36.25300,000$10.9M—
BBIO
NEIL KUMAR—Feb 19, 2025
Proposed Sale
$35.4931,543$1.1M—
BBIO
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018—Jan 28, 2025
Proposed Sale
$36.67600,000$22.0M—
BBIO
NEIL KUMAR—Nov 19, 2024
Proposed Sale
$22.3527,389$612.1K—

← Previous

Page 2 of 2